Cargando…
Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma
Prostaglandin E(2) (PGE(2)) promotes tumor cell proliferation, migration, and invasion, fostering an inflammation-enriched microenvironment that facilitates angiogenesis and immune evasion. However, the PGE(2) receptor subtype (EP1–EP4) involved in neuroblastoma (NB) growth remains elusive. Herein,...
Autores principales: | Hou, Ruida, Yu, Ying, Sluter, Madison N., Li, Lexiao, Hao, Jiukuan, Fang, Jie, Yang, Jun, Jiang, Jianxiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282716/ https://www.ncbi.nlm.nih.gov/pubmed/35732130 http://dx.doi.org/10.1016/j.celrep.2022.111000 |
Ejemplares similares
-
Ablation of Siglec-E augments brain inflammation and ischemic injury
por: Li, Lexiao, et al.
Publicado: (2022) -
Transient inhibition of microsomal prostaglandin E synthase-1 after status epilepticus blunts brain inflammation and is neuroprotective
por: Yasmen, Nelufar, et al.
Publicado: (2023) -
Prostaglandin E2 in neuroblastoma: Targeting synthesis or signaling?
por: Hou, Ruida, et al.
Publicado: (2022) -
Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype
por: Kang, Xu, et al.
Publicado: (2017) -
Chemokine receptors: multifaceted therapeutic targets
por: Proudfoot, Amanda E. I.
Publicado: (2002)